News
-
-
PRESS RELEASE
D. Boral Capital Acted as Sole Bookrunner to Apimeds Pharmaceuticals US, Inc. (NYSE:APUS) in connection with its $13.5 Million Initial Public Offering
Apimeds Pharmaceuticals US, Inc. closes IPO with 3,375,000 shares at $4.00 per share. Proceeds to fund clinical trials and product manufacturing -
-
-
-
PRESS RELEASE
Information regarding the results of the vote on the resolutions presented (and all adopted) at the Annual General Meeting on May 15, 2025
Voltalia reports results of Annual General Meeting vote on resolutions. Shareholders approve financial statements, director term renewal and new director appointments -
-
-
-
